Comparative evaluation of a new Vitek 2 system for identification and antimicrobial susceptibility testing of Streptococcus pneumoniae

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 25, Issue 1, 2006, Pages 55-57

  Abele Horn, M ^a   Stoy, K ^a   Frosch, M ^a   Reinert, R R ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; ETHYLHYDROCUPREINE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; TETRACYCLINE;

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BLOOD; CEREBROSPINAL FLUID; DILUTION; GARDNERELLA VAGINALIS; GRANULICATELLA ADIACENS; MICROCOCCUS LUTEUS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 32144438291     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-0071-1     Document Type: Article

References (11)

1. Abele-Horn M, Suerbaum S, Frosch M (2002) Evaluierung des Vitek 2 in der Routinediagnostik. Der Mikrobiologe 12:1-13
2. Funke G, Monnet D, de Bernardis C, von Graevenitz A, Freney J (1998) Evaluation of the Vitek 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol 36:1948-1953
3. Ligozzi M, Bernini C, Bonora MG, de Fatima M, Zuliani J, Fontana R (2002) Evaluation of the Vitek 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. J Clin Microbiol 40:1681-1686
4. Jorgensen JHA, Barry L, Traczewskib VMM, Sahm DF, McElmeel ML, Crawford SA (2000) Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of bioMérieux Vitek 2. J Clin Microbiol 38:2814-2818
5. Goessens WHF, Lemmens-den Toom N, Hageman J, Hermanns PWM, Sluijter M, de Groot R, Verbrugh HA (2000) Evaluation of the Vitek 2 system for susceptibility testing of Streptococcus pneumoniae isolates. Eur J Clin Microbiol Infect Dis 19:618-622
6. Livermore DM, Struelens M, Amorim J, Baquero F, Bille J, Canton R, Henning S, Gatermann S, Marchese A, Mittermayer H, Nonhoff C, Oakton KJ, Praplan F, Ramos H, Schito GC, Van Eldere J, Verhaegen J, Verhoef J, Visser MR (2002) Multicentre evaluation of the Vitek 2 advanced expert system for interpretive reading of antimicrobial resistance test. J Antimicrob Chemother 49:289-300
7. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing. Approved standard M100-AS15. CLSI, Wayne, Pennsylvania
8. Funke G, Funke-Kissling P (2005) Performance of the new Vitek 2 GP card for identification of medically relevant gram-positive cocci in a routine clinical laboratory. J Clin Microbiol 43:84-88
9. Jorgensen JH, Crawford SA, McElmeel LM, Whitney CG (2004) Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the Vitek 2 instrument. J Clin Microbiol 42:5928-5930
10. Klugmann KP (1996) The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxicillin, and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. J Antimicrob Chemother 38(Suppl A):133-140
11. Palares R, Linares J, Vadillo M, Cabellos C, Manresa F, Vildarich PF, Martin R, Gudiol F (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333:474-480